chr19-15053523-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_012114.3(CASP14):​c.69G>A​(p.Leu23Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00226 in 1,614,048 control chromosomes in the GnomAD database, including 64 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 28 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 36 hom. )

Consequence

CASP14
NM_012114.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0610
Variant links:
Genes affected
CASP14 (HGNC:1502): (caspase 14) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This caspase has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 19-15053523-G-A is Benign according to our data. Variant chr19-15053523-G-A is described in ClinVar as [Benign]. Clinvar id is 777293.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.061 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0115 (1750/152166) while in subpopulation AFR AF= 0.0389 (1616/41510). AF 95% confidence interval is 0.0374. There are 28 homozygotes in gnomad4. There are 809 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 28 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CASP14NM_012114.3 linkuse as main transcriptc.69G>A p.Leu23Leu synonymous_variant 3/7 ENST00000427043.4 NP_036246.1
CASP14XM_011527861.2 linkuse as main transcriptc.69G>A p.Leu23Leu synonymous_variant 3/6 XP_011526163.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CASP14ENST00000427043.4 linkuse as main transcriptc.69G>A p.Leu23Leu synonymous_variant 3/71 NM_012114.3 ENSP00000393417.2 P31944

Frequencies

GnomAD3 genomes
AF:
0.0115
AC:
1745
AN:
152048
Hom.:
28
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0389
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00544
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.0115
GnomAD3 exomes
AF:
0.00319
AC:
802
AN:
251316
Hom.:
14
AF XY:
0.00236
AC XY:
320
AN XY:
135816
show subpopulations
Gnomad AFR exome
AF:
0.0397
Gnomad AMR exome
AF:
0.00254
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000299
Gnomad OTH exome
AF:
0.00522
GnomAD4 exome
AF:
0.00130
AC:
1899
AN:
1461882
Hom.:
36
Cov.:
31
AF XY:
0.00114
AC XY:
832
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.0404
Gnomad4 AMR exome
AF:
0.00291
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000580
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000192
Gnomad4 OTH exome
AF:
0.00311
GnomAD4 genome
AF:
0.0115
AC:
1750
AN:
152166
Hom.:
28
Cov.:
32
AF XY:
0.0109
AC XY:
809
AN XY:
74402
show subpopulations
Gnomad4 AFR
AF:
0.0389
Gnomad4 AMR
AF:
0.00543
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000353
Gnomad4 OTH
AF:
0.0114
Alfa
AF:
0.00480
Hom.:
0
Bravo
AF:
0.0133
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000533

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 31, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
1.6
DANN
Benign
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61731994; hg19: chr19-15164334; API